Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127617331 | 12761733 | 1 | I | 20160913 | 20160920 | 20160920 | PER | US-PFIZER INC-2016433807 | PFIZER | 50.00 | YR | F | Y | 66.00000 | KG | 20160920 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127617331 | 12761733 | 1 | PS | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 1.25 MG, DAILY | Y | 4782 | 1.25 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127617331 | 12761733 | 1 | Hormone replacement therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127617331 | 12761733 | Abdominal pain upper | |
| 127617331 | 12761733 | Chest pain | |
| 127617331 | 12761733 | Feeling abnormal | |
| 127617331 | 12761733 | Gastritis | |
| 127617331 | 12761733 | Goitre | |
| 127617331 | 12761733 | Headache | |
| 127617331 | 12761733 | Thyroid disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127617331 | 12761733 | 1 | 201602 | 201603 | 0 |